Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Operating Leases (2022 - 2026)

GeneDx Holdings has reported Operating Leases over the past 5 years, most recently at $66.3 million for Q1 2026.

  • Quarterly Operating Leases rose 10.7% to $66.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $66.3 million through Mar 2026, up 10.7% year-over-year, with the annual reading at $56.0 million for FY2025, 12.78% down from the prior year.
  • Operating Leases was $66.3 million for Q1 2026 at GeneDx Holdings, up from $56.0 million in the prior quarter.
  • Over five years, Operating Leases peaked at $66.3 million in Q1 2026 and troughed at $56.0 million in Q4 2025.
  • The 5-year median for Operating Leases is $62.0 million (2024), against an average of $61.4 million.
  • Year-over-year, Operating Leases rose 11.14% in 2023 and then fell 12.78% in 2025.
  • A 5-year view of Operating Leases shows it stood at $60.0 million in 2022, then increased by 4.87% to $62.9 million in 2023, then grew by 2.09% to $64.3 million in 2024, then dropped by 12.78% to $56.0 million in 2025, then grew by 18.35% to $66.3 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Operating Leases are $66.3 million (Q1 2026), $56.0 million (Q4 2025), and $57.2 million (Q3 2025).